RECRUITING

Angiography and Electrogram Guided Bachmann Bundle Pacing

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

People eligible for this study are scheduled to have a permanent pacemaker (PPM) or defibrillator device (ICD) implanted as part of their routine care. This device will also have a wire placed in the right atrium (RA) of the heart. As an alternative to the RA, the wire can also be placed in the Bachmann bundle (BB). This study is being done to compare two options to help place the wire in the Bachmann bundle. One option uses contrast dye and x-ray, and the other option uses electrocardiogram (ECG) and contrast dye and x-ray. We want to learn more about how well these options work in implanting the wire in the Bachmann bundle. Both of these options are FDA approved and used in standard practice.

Official Title

Angiography and Electrogram Guided Bachmann Bundle Pacing - ANGEL BBP

Quick Facts

Study Start:2025-08-15
Study Completion:2027-12-26
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07110922

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patients \> 18 years of age
  2. 2. Patient with an indication for permanent pacemaker or ICD utilizing atrial pacing lead
  3. 3. Patient is willing to comply with all study procedures and be available for the duration of the study.
  1. 1. Inability to provide informed consent
  2. 2. Pregnant
  3. 3. Enrolled in a concurrent study that may confound the results of this study.
  4. 4. Persistent atrial fibrillation at the time of implant (if cardioversion contraindicated at the time of implant, where BB mapping cannot be performed in sinus rhythm)
  5. 5. Renal dysfunction with serum Creatinine \>3.0 mg/dl

Contacts and Locations

Study Contact

Pugazhendhi Vijayaraman, MD
CONTACT
570-808-6020
pvijayaraman1@geisinger.edu

Principal Investigator

Pugazhendhi Vijayaraman, MD
PRINCIPAL_INVESTIGATOR
Geisinger Clinic

Study Locations (Sites)

Geisinger Wyoming Valley
Wilkes-Barre, Pennsylvania, 18711
United States

Collaborators and Investigators

Sponsor: Pugazhendhi Vijayaraman

  • Pugazhendhi Vijayaraman, MD, PRINCIPAL_INVESTIGATOR, Geisinger Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-15
Study Completion Date2027-12-26

Study Record Updates

Study Start Date2025-08-15
Study Completion Date2027-12-26

Terms related to this study

Additional Relevant MeSH Terms

  • Heart Diseases